Murine monoclonal antibody protective against Plasmodium vivax malaria
US6399062B1 · kind B1 · utility
1Cited by
2References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 28, 1993 |
| Grant date | Jun 4, 2002 |
| Priority date | — |
| Expiry date | Dec 28, 2013 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a passive protective agent against P. vivax. The passive protective agent is an antibody that, when a concentration of the antibody is injected intravenously, protects a subject to the limits of that concentration of antibody from developing malaria when the subject is subsequently challenged with live, infectious P. vivax sporozoites. The invention includes methods of treatment and pharmaceutical formulations of the agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.